Valuation: Cencora, Inc.

Market Cap 60.69B 51.99B 48.64B 44.53B 83.57B 5,807B 84.67B 575B 224B 2,917B 228B 223B 9,648B P/E 2026 *
17.4x
P/E 2027 * 19x
Enterprise Value 68.37B 58.57B 54.8B 50.17B 94.15B 6,542B 95.39B 647B 252B 3,286B 257B 251B 10,870B EV / Sales 2026 *
0.2x
EV / Sales 2027 * 0.2x
Free-Float
61.21%
Yield 2026 *
0.75%
Yield 2027 * 0.77%
1 day+0.74%
1 week+0.52%
Current month+0.48%
1 month+2.22%
3 months+19.27%
6 months-10.98%
Current year-5.02%
1 week 267.2
Extreme 267.2
275.9
1 month 264.9
Extreme 264.9
287.4
Current year 216.4
Extreme 216.4
320.9
1 year 216.4
Extreme 216.4
325.35
3 years 161.46
Extreme 161.46
325.35
5 years 137.06
Extreme 137.06
325.35
10 years 137.06
Extreme 137.06
325.35
Manager TitleAgeSince
Chief Executive Officer 59 2024-09-30
Director of Finance/CFO 59 2026-06-28
Chief Tech/Sci/R&D Officer 50 2024-11-03
Director TitleAgeSince
Director/Board Member 75 2013-05-15
Director/Board Member 59 2024-09-30
Chairman 64 2025-09-30
Change 5-day change 1-year change 3-year change Capi.($)
+0.74%+0.52% - - 60.69B
+2.19%+4.84%-11.64%+12.29% 202B
+1.14%+2.28%+2.47%+14.39% 119B
+1.06%+1.34%+4.88%+75.73% 60.69B
-1.37%-6.57%+28.86%+58.31% 52.38B
+2.33%+4.69%-2.35%-30.34% 52.3B
+2.35%+2.89%+14.54%-11.79% 34.85B
+5.16%-4.14% - - 30.06B
-0.20%+1.05%+45.52%-10.08% 24.85B
-0.29%-3.87%-6.22%+24.74% 23.84B
Average +1.31%+0.28%+9.51%+16.66% 66.7B
Weighted average by Cap. +1.46%+1.90%+1.97%+17.88%

Financials

2026 *2027 *
Net sales 337B 289B 270B 247B 464B 32,260B 470B 3,193B 1,245B 16,206B 1,266B 1,238B 53,602B 355B 304B 285B 261B 489B 33,987B 496B 3,364B 1,312B 17,073B 1,334B 1,305B 56,471B
Net income 3.58B 3.07B 2.87B 2.63B 4.93B 343B 4.99B 33.9B 13.22B 172B 13.44B 13.15B 569B 2.84B 2.44B 2.28B 2.09B 3.92B 272B 3.97B 26.94B 10.51B 137B 10.68B 10.45B 452B
Net Debt 7.68B 6.58B 6.16B 5.64B 10.58B 735B 10.72B 72.76B 28.38B 369B 28.85B 28.23B 1,222B 9.44B 8.08B 7.56B 6.92B 12.99B 903B 13.16B 89.36B 34.85B 454B 35.43B 34.66B 1,500B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
26-08-21 €271.70 +0.74%
26-08-20 €269.70 -0.52%
26-08-19 €271.10 -0.77%
26-08-18 €273.20 +1.22%
26-08-17 €269.90 -0.15%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
318.04USD
Average target price
369.31USD
Spread / Average Target
+16.12%

Quarterly revenue - Rate of surprise